Statins After 70: Could These Cheap Pills Cut the Risk of Heart Attack and Dementia?
For millions of older adults, a familiar cholesterol-lowering medicine could have benefits that extend beyond its traditional role in protecting the heart.
New research has renewed interest in the potential benefits of statins for people in later life. The findings suggest that these widely used medicines may reduce the likelihood of serious cardiovascular problems among people over 70, while separate research indicates a possible association between statin use and a lower risk of dementia in people with type 2 diabetes.
Statins are already among the most frequently prescribed medicines in the NHS. However, questions have remained about how much benefit they provide to people in older age, particularly those who have not previously experienced cardiovascular disease.
The latest findings could encourage doctors to take a closer look at statin treatment for some older patients.
What are statins?
Statins are medicines designed to reduce levels of cholesterol in the blood. In particular, they help lower low-density lipoprotein, commonly referred to as LDL or "bad" cholesterol.
Too much cholesterol can contribute to the build-up of fatty deposits inside blood vessels. Over time, this can restrict blood flow and increase the risk of cardiovascular conditions, including coronary heart disease, heart attacks and strokes.
According to the information in the supplied source, lower-dose statins can reduce LDL cholesterol by up to around 30 per cent, while higher doses can reduce it by more than 40 per cent.
Because of their effect on cholesterol, statins have become an important part of cardiovascular disease prevention and treatment.
New findings involving people over 70
One of the most significant findings highlighted in the report comes from a trial conducted by researchers at Monash University in Australia.
The study compared approximately 5,000 people over the age of 70 who were taking statins with another group of around 5,000 who were not taking them.
After six years of follow-up, the people taking statins were reported to have experienced major cardiovascular events at a lower rate. The research was described as showing an approximately 30 per cent reduction in the risk of heart attack or stroke compared with those not taking statins.
This is particularly notable because statin treatment in older adults has been the subject of debate. Age alone does not necessarily determine whether someone will benefit from cholesterol-lowering treatment, and individual cardiovascular risk remains an important consideration.
Dr Roy Jogiya of Heart Research UK, quoted in the source report, described the reduction in major cardiovascular events as substantial. He also stressed that the findings should not be interpreted as meaning that every person over 70 should automatically receive statins.
Instead, the results could provide doctors with stronger evidence when considering treatment for older people who might previously have been thought less likely to benefit.
A possible link with dementia risk
The potential benefits of statins may not be limited to cardiovascular health.
A separate study from Copenhagen University Hospital examined people with type 2 diabetes. The research involved 132,585 individuals and found that people taking statins were reported to be around 10 to 15 per cent less likely to develop dementia.
The findings are particularly relevant because type 2 diabetes is already associated with an increased risk of several health complications, including cardiovascular disease.
The research does not prove that statins directly prevent dementia. An association between taking a medicine and experiencing a lower risk does not necessarily mean the medicine itself caused that reduction. Other factors may also influence the results.
Nevertheless, the findings add to continuing scientific interest in the relationship between cardiovascular health, cholesterol and brain health.
Both studies highlighted in the report were presented at the European Society of Cardiology congress in Munich.
Why the findings matter
Statins are inexpensive and widely available, which could make any potential benefits particularly significant at a population level.
The source report states that around seven to eight million people in the UK currently take statins, while many more are believed to meet existing eligibility criteria.
At the same time, the UK has a large and growing older population. The report estimates that there are around eight million people aged over 70 in the country.
If further research confirms that carefully selected older adults can benefit substantially from statins, the findings could influence future discussions about cardiovascular prevention in later life.
However, treatment decisions need to be based on individual circumstances rather than age alone.
Who may be offered statins?
According to NHS guidance cited in the source material, statins may be offered to people who have a higher risk of developing cardiovascular disease when lifestyle changes have not been enough, or when lifestyle changes alone are unlikely to provide sufficient protection.
They can also be prescribed to people who already have cardiovascular disease, with the aim of reducing their risk of future heart attacks and strokes.
Lifestyle remains an important part of cardiovascular health. A balanced diet, regular physical activity, maintaining a healthy weight where appropriate, avoiding smoking and managing other health conditions can all play a role in reducing cardiovascular risk.
For some people, medication and lifestyle measures may work together as part of a broader prevention strategy.
Are statins suitable for everyone?
No. Statins are prescription medicines, and the decision to take them should be made with a healthcare professional.
They can interact with certain medicines and other substances. The source material specifically highlights potential interactions involving some blood pressure medicines, antifungal treatments, certain antibiotics, HIV medicines, warfarin, ciclosporin, colchicine, fusidic acid and St John's wort.
Grapefruit and grapefruit juice can also increase the risk of side effects with certain statins.
Anyone already taking medication should therefore check with their doctor or pharmacist before starting, stopping or changing treatment.
People who experience concerning or persistent side effects should also seek medical advice rather than changing their medication without professional guidance.
What should older adults take from the research?
The emerging evidence offers an encouraging reason to continue studying the role of statins in older people.
The findings suggest that some adults over 70 may still gain meaningful cardiovascular protection from statin treatment. Research involving people with type 2 diabetes also raises interesting questions about whether cholesterol-lowering treatment could be linked to a reduced risk of dementia.
However, these findings should not be interpreted as a recommendation for everyone to take statins.
The most appropriate treatment depends on a person's cardiovascular risk, existing medical conditions, other medicines, age, preferences and overall health. A healthcare professional can assess these factors and explain whether treatment is appropriate.
As populations continue to age, understanding how best to prevent heart and circulatory disease in later life is becoming increasingly important. Statins may form one part of that picture, but ongoing research will be needed to establish exactly who benefits most and how these medicines should be used in older adults.
Source
The Sun on 30 August 2026, which cites research from Monash University, Copenhagen University Hospital and comments from Heart Research UK and the European Society of Cardiology.
Disclaimer
This article is for general informational purposes only and is not medical advice. The research described does not mean that statins are suitable for everyone, nor does it establish that statins directly prevent dementia. Medication decisions should be made with a qualified doctor or pharmacist, taking individual health circumstances and potential drug interactions into account. Do not start, stop or change prescribed medication without professional medical advice.